Abstract
International Journal of the Economics of Business produced a special issue on “Symposium on the US brand name prescription drug antitrust legislation” in 1997. This case involved fascinating scientific and policy issues including price discrimination. Economic scholars contributed to the debate. This paper gives a management accountant’s view on the competition policy issue. It clarifies the competition policy issue diagnostic tools (an analytical construct and concepts of cost). These diagnostic tools haave been able to give insights into the issue.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
